Stay updated with breaking news from Nasdaq Envb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Enveric Biosciences (NASDAQ:ENVB – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $10.00 target price on the stock. HC Wainwright also issued estimates for Enveric Biosciences’ Q4 2023 earnings at ($1.50) EPS, FY2023 earnings at ($8.10) […]
AdvisorShares Investments LLC raised its holdings in Enveric Biosciences, Inc. (NASDAQ:ENVB – Free Report) by 46.2% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 146,833 shares of the company’s stock after acquiring an additional 46,404 shares during the quarter. AdvisorShares Investments LLC owned approximately […]
AdvisorShares Investments LLC raised its stake in shares of Enveric Biosciences, Inc. (NASDAQ:ENVB – Free Report) by 46.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,833 shares of the company’s stock after acquiring an additional 46,404 shares during […]
Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report)’s share price fell 1% during trading on Wednesday . The company traded as low as $1.34 and last traded at $1.36. 18,133 shares were traded during mid-day trading, a decline of 98% from the average session volume of 953,973 shares. The stock had previously closed at $1.37. […]
Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 10,900 shares, a decrease of 55.0% from the September 15th total of 24,200 shares. Currently, 0.6% of the company’s shares are sold short. Based on an […]